Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of mitochondrial complex I induces progressive parkinsonism
Patricia González‐Rodríguez, Enrico Zampese, Kristen A. Stout, et al.
Nature (2021) Vol. 599, Iss. 7886, pp. 650-656
Open Access | Times Cited: 368

Showing 1-25 of 368 citing articles:

The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 215
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 142
Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
Masaru Tanaka, Ágnes Szabó, Eleonóra Spekker, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2607-2607
Open Access | Times Cited: 130
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Jie Li, Dongming Yang, Zhiping Li, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101817-101817
Closed Access | Times Cited: 112
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong Yao, Hao Li, Peng Liao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 83
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 74
Mitochondrial complex I ROS production and redox signaling in hypoxia
Chidozie Nwabuisi Okoye, Shon A. Koren, Andrew P. Wojtovich
Redox Biology (2023) Vol. 67, pp. 102926-102926
Open Access | Times Cited: 70
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 67
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
María Teresa Ibarra-Gutiérrez, Norma Serrano‐García, Marisol Orozco‐Ibarra
Molecular Neurobiology (2023) Vol. 60, Iss. 4, pp. 1929-1948
Closed Access | Times Cited: 66
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 66
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 51
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 50
Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage
Yao Wei, QianQian Miao, Qian Zhang, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 12, pp. 2081-2089
Closed Access | Times Cited: 50
A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
Kimberly C. Paul, Richard C. Krolewski, Edinson Lucumi Moreno, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Diet-Derived Antioxidants: The Special Case of Ergothioneine
Barry Halliwell, Richard M.Y. Tang, Irwin K. Cheah
Annual Review of Food Science and Technology (2023) Vol. 14, Iss. 1, pp. 323-345
Open Access | Times Cited: 39
Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 36
Ameliorating Mitochondrial Dysfunction of Neurons by Biomimetic Targeting Nanoparticles Mediated Mitochondrial Biogenesis to Boost the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Hao Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 36
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology
Thomas Goralski, Lindsay Meyerdirk, Libby Breton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Key genes and convergent pathogenic mechanisms in Parkinson disease
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 24
Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 18
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 17
Synapses: The Brain’s Energy-Demanding Sites
Andreia Faria‐Pereira, Vanessa A. Morais
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3627-3627
Open Access | Times Cited: 61
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 398-398
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top